Benign prostatic hyperplasia/urinary retention:

Indications for: UROXATRAL

Benign prostatic hyperplasia (BPH).

Limitations of Use:

Not for use in children or for the treatment of hypertension.

Adult Dosage:

Swallow whole. Take immediately after same meal each day. 10mg once daily.

Children Dosage:

Not applicable.

UROXATRAL Contraindications:

Concomitant potent CYP3A4 inhibitors (eg, ketoconazole, itraconazole, ritonavir). Moderate or severe hepatic impairment.

UROXATRAL Warnings/Precautions:

Not for use in women. Discontinue if angina develops or worsens. Severe renal insufficiency (CrCl <30mL/min). Hypotension. Mild hepatic impairment. History of QT interval prolongation. Exclude prostate cancer prior to initiation. Cataract surgery (intraoperative floppy iris syndrome possible).

UROXATRAL Classification:

Alpha-1 blocker.

UROXATRAL Interactions:

See Contraindications. Do not use with other α-blockers. Increased hypotension with concomitant nitrates, PDE5 inhibitors, other antihypertensives. Potentiates and is potentiated by cimetidine. Potentiates cardiovascular effects of atenolol. Caution with drugs that prolong QT interval.

Adverse Reactions:

Dizziness, upper respiratory tract infection, headache, fatigue; postural hypotension, syncope; rare: priapism.

How Supplied:

Tabs—30, 100